|
|
||||||||
Department of Zoology and Regulatory Biosciences Center, North Dakota State University, Fargo, North Dakota 58105
| |
ABSTRACT |
|---|
|
|
|---|
Previously, we isolated a 624-bp cDNA encoding for a 115-amino acid preprosomatostatin containing [Tyr7,Gly10]-somatostatin (SS)-14 (now designated PPSS-II') obtained from the endocrine pancreas (Brockmann bodies) of rainbow trout. In this study we have characterized a second cDNA obtained from trout pancreas that is 600-bp in length and encodes for a 111-amino acid precursor containing [Tyr7,Gly10]-SS-14 (PPSS-II''). The nucleotide and amino acid identity between the two cDNAs is 82.3 and 80.5%, respectively. Both PPSS-II' and PPSS-II'' mRNA were present in esophagus, pyloric ceca, stomach, upper and lower intestine, and pancreas, whereas only SS-II'' mRNA was present in brain. PPSS-II'' mRNA was more abundant than PPSS-II' mRNA in pancreas, whereas PPSS-II' mRNA was more abundant than PPSS-II'' mRNA in stomach. Fasting increased pancreatic PPSS-II'' mRNA levels but had no effect on the levels of PPSS-II' mRNA. These results indicate the existence of two nonallelic pancreatic SS-II genes that are differentially expressed, both in terms of distribution among tissues and in terms of relative abundance within the tissues.
pancreatic somatostatin-II gene; preprosomatostatin-I; preprosomatostatin-II
| |
INTRODUCTION |
|---|
|
|
|---|
SOMATOSTATIN (SS) was first isolated as a 14-amino acid peptide from ovine hypothalamus and found to inhibit the release of growth hormone from the pituitary gland (5). Since this initial discovery, SSs have been isolated from numerous tissues in a variety of chemical forms and found to possess a vast array of physiological roles, including neuromodulation, osmoregulation, and the coordination of growth, development, and metabolism (31). The different forms of SSs observed in mammals (e.g., SS-25, SS-28) are NH2-terminal extensions of SS-14 and result from differential processing of the same precursor, preprosomatostatin-I (PPSS-I) (7). A survey of vertebrates reveals the widespread distribution of PPSS-I as SS-14 has been isolated from representative cyclostomes, elasmobranchs, teleost fish, amphibians, reptiles, and birds (10).
Teleost fish, in addition to expressing PPSS-I, also possess a second somatostatin precursor, PPSS-II, a molecule that contains [Tyr7,Gly10]-SS-14 at its COOH terminus. The amino acid sequences of PPSS-II products obtained directly from islet extracts are known for coho salmon (33), eel (9), goldfish (40), sculpin and flounder (8), and tilapia (28). Evidence that teleost PPSSs derive from different mRNAs was first reported in anglerfish (16-18); two cDNAs were obtained from pancreatic islets of this species, one encoding for PPSS-I and the other encoding for PPSS-II. Despite the existence of multiple cDNAs encoding for PPSSs in anglerfish (16-18) and catfish (21, 24), definitive information regarding the potential differential expression of somatostatin genes has not been reported.
In this study, we used rainbow trout to characterize further the polygenic origin of SS in vertebrates and to evaluate the expression of SS gene products. Rainbow trout are particularly well-suited for this investigation because of the organization of their pancreas, in which the endocrine component (Brockmann body) is anatomically separate from the exocrine component and because the Brockmann body contains comparatively large amounts of SS peptide isoforms localized in discrete cell populations (29).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals. Juvenile rainbow trout, Oncorhynchus mykiss, were obtained from the Garrison National Fish Hatchery near Riverdale, ND. Fish were maintained at North Dakota State University in well-aerated, dechlorinated municipal freshwater (14°C) under 12:12-h light-dark photoperiod and fed to satiety twice daily with Supersweet Feeds (Glenco, MN) trout grower, except 24 h before experiments. In the nutritional state experiment, fish were either fed as usual or fasted for 2 wk before sample collection.
RNA extraction. Tissues were removed
from rainbow trout of both sexes after the animals had been
anesthetized with 0.01% (wt/vol) 3-aminobenzoic acid ethyl ester
(MS-222, Sigma) buffered with 0.2% (wt/vol) sodium bicarbonate. Tissue
samples (~25 mg) were placed in 2-ml microfuge tubes and immediately
frozen on dry ice. Total RNA was extracted by a modification of the
RNAzol method (Cinna/Biotecx Laboratories, Friendswood, TX) described
previously (25). Total RNA was quantified by ultraviolet (UV)
A260 spectrophotometry and diluted
to 15 µg/µl. RNA samples were stored at
90°C until used.
Isolation and sequence analysis of PPSS
cDNA. A two-phase rapid amplification of cDNA ends
(RACE) PCR-based approach was used for the isolation and
characterization of selected cDNA sequences as described previously
(25). Briefly, in phase
I (Fig.
1A), endogenous poly-A RNA was reverse transcribed from 15 µg of trout pancreatic total RNA with Superscript II reverse transcriptase (GIBCO
BRL, Gaithersburg, MD) and a 37-nucleotide antisense adapter primer
(GIBCO BRL). Five microliters of the reverse transcription reaction
were used as a template for 3'-RACE PCR with a 21-base somatostatin gene-specific primer (GSP-1;
5'-GGCTGCAAGAATTTCTTCTCG-3') and the universal
amplification primer (GIBCO BRL). After an initial denaturation cycle
of 94°C for 5 min, 39 PCR cycles were performed, each consisting of
1 min denaturation (94°C), 1 min annealing (42°C), and 1 min
extension (72°C). In the last cycle, the extension time was
increased to 10 min to ensure complete extension. The resulting PCR
product was identified by electrophoresis on an agarose gel containing
1% (wt/vol) agarose (GIBCO BRL) and 2% (wt/vol) NuSeive GTG agarose
(FMC Bioproducts, Rockland, ME) in 1× Tris-borate-ethylenediamine
tetraacetic acid followed by ethidium bromide staining and
UV transillumination. Amplified fragments were directly cloned into the
TA cloning vector PCR 2000 (Invitrogen, San Diego, CA). Positive colonies were identified by
agarose gel electrophoresis, as described above, of restriction enzyme
digests (EcoR I; Promega, Madison, WI)
of purified plasmid preparations (12). One to two micrograms of plasmid
DNA was denatured and sequenced by the dideoxy chain-termination method
(Sequenase Kit; US Biochemicals, Cleveland, OH) according to the
manufacturer's protocol. All sequences were confirmed by sequencing
multiple colonies from at least three independent PCR reactions and
with two or more different primers in both directions. In
phase
II (Fig.
1A), isolation of the 5'
cDNA sequence was accomplished by 5'-RACE PCR (GIBCO BRL). SS
mRNA was exclusively reverse transcribed from pancreatic total RNA
using a 20-base antisense oligonucleotide primer complementary to a
region of the 3' fragment isolated in phase
I (GSP-2;
5'-GTTGGCGGTGTGACGTGATTG-3'). The resulting cDNA was
purified twice over Glass Max spin columns (GIBCO BRL) to remove
unincorporated dNTPs and primer and then "tailed" at the 3'
end with dCTP using terminal deoxynucleotidyl transferase (GIBCO BRL).
Five microliters of the tailing reaction were used as a template for
5'-RACE PCR with GSP-2 and anchor primer (GIBCO BRL). Thirty-nine
PCR cycles were performed as in 3'-RACE PCR, except Taq polymerase (Perkin-Elmer, Norwalk,
CT) was pipetted beneath the layer of mineral oil after the initial
5-min denaturation cycle (26). The amplified product was identified by
agarose gel electrophoresis, cloned, and sequenced as described above.
|
Slot-blot quantitation of mRNA. The
amount of PPSS-II' and PPSS-II'' mRNA in pancreas and
stomach was quantitated by slot-blot analysis (6), a technique similar
to RNase protection assay in that it relies on reference to in
vitro-synthesized RNA standards and has a sensitivity of
~106 molecules but lends itself
more readily to the analysis of numerous samples. cRNA standards were
made by first cloning full-length SS-II' and SS-II''
cDNAs in the sense orientation into the PCR 2000 cloning vector (Invitrogen). After linearization
with EcoR V (Promega; for SS-II'
inserts) or BamH I (Promega; for
SS-II'' inserts), in vitro RNA synthesis was performed
using T7 RNA polymerase (40 units; Promega), according to the
manufacturer's protocol. Full-length cRNA was separated from
unincorporated NTPs by ultrafiltration (100,000 mol wt cutoff;
Millipore, Bedford, MA) followed by ethanol precipitation (1/4 volume
NaCl, 2× volume absolute ethanol) at
20°C overnight.
After recovery of RNA by centrifugation (12,000 g for 20 min at 4°C), RNA was
resuspended in 100 ml sterile water and quantitated by UV
A260 spectrophotometry. The
homogeneity of cRNA standard preparations was assessed by
electrophoresis on a 6% polyacrylamide/8.0 M urea gel and verified by
sequence analysis. Northern analysis (19) was performed to evaluate the number and size of transcripts as well as to verify that the specific oligonucleotide probes hybridized only with SS-II' and
SS-II'' transcripts in the total RNA extracted
from the Brockmann bodies of trout. Four hundred-fifty microliter
replicate dilutions of standards [serially diluted in sterile
water containing yeast tRNA (10 µg/ml) and RNasin (80 U/ml;
Promega)] and pancreatic total RNA samples [10 µg were
initially diluted with sterile water to a final volume of 50 µl, to
which was added 20 µl of 37% formaldehyde and 30 µl of 20×
saline sodium citrate (3 M NaCl, 0.3 M
Na3C6H5O7 · 2H2O,
pH 7.0); after incubation at 65°C for 15 min, the RNA samples were
immediately placed on ice and diluted further with 1,000 µl of
ice-cold 10× saline sodium citrate] were slotted directly onto 0.2 µm Nytran membrane (Schleicher and Schuell) and hybridized, individually, with either SS-II'-specific,
SS-II''-specific, or SS-II'/SS-II''-common (standards only; for
normalization of RNA amount) radiolabeled oligonucleotide probes as
described above. The resulting autoradiograms were quantified by
scanning laser densitometry (Molecular Dynamics, Sunnyvale, CA).
Statistical differences were estimated by a two-tailed Student's
t-test
(n = 12;
P < 0.05).
RNA template-specific PCR. RNA template-specific PCR (RS-PCR) was used to qualitatively evaluate the expression of PPSS-II' and PPSS-II'' mRNAs in various tissues because of its high specificity (amplification of false positives derived from contaminating genomic DNA is excluded) and high sensitivity (36). A d17t30 primer (5'-CATGTACCTTGATCAACCGTCACGTGGCAGCCAGTAGAAGTTCTTGC-3'), containing 17 bases at its 3' end complementary to both SS-II' and SS-II'' (d17) and 30 bases of nonspecific tagging sequence at its 5' end (t30), was used to coreverse transcribe PPSS-II' and PPSS-II'' mRNA in total RNA isolated from tissues. Five- microliter (15 µg) duplicate aliquots of total RNA were placed in 0.5-ml microfuge tubes and either stored at 4°C or incubated with 5 units of RNase-A (Sigma) for 30 min at 37°C. After RNase-A pretreatment, the remaining reaction components were added to both tube sets (20 µl total volume) so that the final composition was 20 mM Tris · HCl (pH 8.4), 50 mM KCl, 2.5 mM MgCl2, 100 µg/ml BSA, 10 mM dithiothreitol, 0.5 µM primer, 2 mM dNTPs, and 5 units of AMV reverse transcriptase (Promega). The reactions were incubated at 37°C for 1 h and stored on ice until used as a template for PCR. Five microliters of the reverse transcription reaction were used as a template for PCR in a final reaction containing 50 mM KCl, 10 mM Tris · HCl (pH 8.3 at 25°C), 1.5 mM MgCl2, 0.01 mg/ml gelatin, 200 µM of each dNTP, 0.5 µM upstream SS u30 primer (5'-ATTTGCA GCCAAGGAGCCGCCTCGCAGCC-3'), 0.5 µM downstream t30 primer (identical to the t30 region of the d17t30 primer; 5'-CATGTACCTTGATCAACCGTCTCGTGGCAG-3'), and 0.04 units of Taq DNA polymerase (Perkin Elmer) overlaid with 50 µl of sterile mineral oil. To increase specificity, the annealing temperature was raised to 65°C, and 39 PCR cycles were performed as described previously.
The resulting RS-PCR products were subjected to Southern blot analysis.
The amplified cDNAs were separated by agarose gel electrophoresis as
described above, and the gel was blotted by capillary transfer to
0.45-µm nitrocellulose membrane (Schleicher and Schuell) overnight
(34). The membrane was baked in a vacuum oven (80°C) for 2 h and
prehybridized in hybridization solution [5× SSPE (20×
solution: 3 M NaCl, 0.2 M
NaH2PO4,
0.02 M EDTA-Na2), 5×Denhardt's solution (100× solution: 10 g
polyvinylpyrrolidone, 10 g BSA, 10 g Ficoll 400, H2O to 500 ml), and 0.5%
(vol/vol) SDS] containing 0.1 mg/ml denatured salmon sperm DNA
for 2 h at 37°C. The prehybridization mixture was removed, and the
membrane was hybridized at 37°C overnight in hybridization solution
containing 353-base SS-II cDNA radiolabeled (1×
106 cpm/ml) probe. The blot was
washed twice with 2× SSPE containing 0.2% (vol/vol) SDS for 20 min at 65°C, and autoradiography was performed (30 h exposure at
90°C using Fuji RX film).
To determine which of the two mRNA species (PPSS-II' and PPSS-II'') were expressed within various tissues, RS-PCR products were subjected to slot-blot analysis. Briefly, 10 µl of RS-PCR product were boiled for 5 min in a 1.5-ml microfuge tube and then immediately placed on ice and diluted with 1,000 µl ice-cold 5× SSPE. Four hundred-fifty microliters were then slotted in duplicate directly to 0.2 µm Nytran membrane (Schleicher and Schuell) using a Minifold II slot-blot apparatus (Schleicher and Schuell) under weak vacuum. The wells were washed twice with 500 µl of 5× SSPE, and the membrane was allowed to air dry. The duplicate blots were baked, prehybridized, and hybridized with either SS-II'-specific or SS-II''-specific radiolabeled (1 × 106 cpm/ml) oligonucleotide probes. The blots were then washed and autoradiographed as described above.
Primers and probes. Oligonucleotides
were either custom synthesized by National Biosciences (Plymouth, MN)
or supplied with GIBCO BRL 3'- and 5'-RACE kits.
Oligonucleotides used as probes were 5'-end labeled with
-[32P]ATP
(Amersham) using T4-polynucleotide kinase (Promega) (34). The
full-length SS-II cDNA probe was radiolabeled with
-[32P]CTP by random
priming (Prime-a-Gene; Promega) according to the manufacturer's
protocol. All radiolabeled probes were purified over Elutip-D columns
(Schleicher and Schuell) according to the manufacturer's protocol.
Data analysis. Nucleotide and deduced amino acid sequences (coding regions only) were aligned and analyzed with the DOS-based PsiNine DNA/protein analysis program (North Dakota State University, Department of Biochemistry) and OMIGA 1.0 for Windows 95/NT (Oxford Molecular Group, Campbell, CA). Quantitative data are expressed as means ± SE. The two-tailed Student's t-test was used to estimate differences between treatment groups. A probability level of 0.05 was used to indicate significance. All statistics were performed using SigmaStat (Jandel Scientific, Palo Alto, CA).
| |
RESULTS |
|---|
|
|
|---|
Rainbow trout possess two cDNAs encoding PPSSs that contain [Tyr7,Gly10]-SS-14. An ~260-bp fragment was amplified by 3'-RACE PCR from reverse-transcribed total RNA isolated from trout pancreas using an SS-specific upstream primer (GSP-1, Fig. 1). Sequence analysis of this 3' fragment (actual length = 243 bp) revealed six codons followed by a stop codon with 100% identity to the last six codons (+9 to +14) of a trout PPSS containing [Tyr7,Gly10]-SS-14 recently identified and reported by our laboratory (25); the remainder of the fragment consisted of 3'-untranslated region, including a polyadenylated tail at the most 3' end. Reverse transcription and 5'-RACE PCR with our previously designed GSP-2 primer resulted in the amplification of a 561-bp fragment identical in sequence to that which we reported previously (25). Reverse transcription and 5'-RACE PCR with a newly designed antisense primer unique to the new 3' fragment resulted in the amplification of a 544-bp fragment (Fig. 1B). Overlapping sequence of the 243-bp 3'-RACE and 544-bp 5'-RACE fragments identified a novel 600-bp cDNA encoding for a second PPSS containing [Tyr7,Gly10]-SS-14, which we have designated PPSS-II'', with a single putative initiation site 101 bases downstream from the most 5' end and two putative polyadenylation signal sites. Exhaustive screening of 18-23 colonies from each of three independent 3'-RACE and 5'-RACE PCRs confirmed the existence of only two cDNAs, one encoding PPSS-II'' and one identical to our previously reported sequence (25) that encodes for the precursor we now designate PPSS-II'.
A comparison between PPSS-II'' and our previously reported
sequence (25) is shown in Fig. 2. Although
PPSS-II' is a 115-amino acid protein containing numerous putative
recognition sites for posttranslational modification by converting
enzymes, potentially yielding a 28-amino acid SS peptide with
[Tyr7,Gly10]-SS-14
at its COOH terminus, PPSS-II'' is a 111-amino acid protein potentially processed to a 25-amino acid SS peptide containing [Tyr7,Gly10]-SS-14
at its COOH terminus. SS-II' and SS-II'' share 82.3%
nucleotide and 80.5% amino acid identity.
|
Despite the similarity of sequence between SS-II' and
SS-II'', we took advantage of a 50-base region immediately
upstream from the COOH termini of the SS coding regions to design three 20-base oligonucleotides that would specifically bind to SS-II' mRNA, SS-II'' mRNA, or to both SS-II' and
SS-II'' mRNAs (the specificity of these probes was verified
by hybridization to in vitro synthesized RNA; see Fig.
6A). Northern analysis using these
probes revealed that there was a single transcript encoding
PPSS-II' and a single transcript encoding PPSS-II''
(Fig. 3).
|
Two PPSS-II mRNAs are differentially expressed in
various tissues. RNA from various tissues was extracted
and reverse transcribed. The resulting cDNAs encoding for
PPSS-II' and PPSS-II'' were coamplified by RS-PCR,
electrophoresed on agarose, and subjected to Southern blot analysis
using a full-length SS-II cDNA probe (which does not distinguish
between SS-II' and SS-II''). With this approach, PPSS-II mRNA was detected in brain, esophagus, pyloric ceca, stomach, upper and lower intestine, and Brockmann bodies (Fig.
4). Duplicate samples pretreated with
RNase demonstrated that amplified products were exclusively derived
from RNA templates and not false positives derived from contaminating
genomic DNA.
|
When slot-blot analysis of RS-PCR products was performed using
gene-specific oligonucleotide probes that distinguish PPSS-II' and PPSS-II'' mRNA, we detected the presence of
PPSS-II' and PPSS-II'' mRNA in esophagus, pyloric
ceca, stomach, upper and lower intestine, and Brockmann bodies,
although only PPSS-II'' mRNA was present in brain (Fig.
5).
|
Abundance of PPSS-II mRNAs is different in various
tissues. Hybridization of the gene-specific
oligonucleotide probes to replicate slot-blots containing known
quantities of in vitro-synthesized PPSS-II' and
PPSS-II'' cRNA standards, in the range of 6.5 × 108 to 5.0 × 109 molecules, and RNA extracted
from selected tissues allowed for the accurate evaluation of the
amounts of PPSS-II' and PPSS-II'' mRNAs (Fig.
6). We used this approach to examine the
expression of PPSS-II' and of PPSS-II'' mRNAs in
Brockmann bodies (endocrine pancreas) and stomachs removed from animals
under normal (fed to satiety twice per day except 24 h before sampling)
physiological conditions. Under these conditions, pancreatic
SS-II'' mRNA levels were nearly threefold higher than those
of SS-II', estimated to be 8.7 × 108 molecules/µg total RNA and
3.2 × 108 molecules/µg
total RNA, respectively (Fig.
7A). The
concentrations of PPSS-II mRNAs were lower in stomach than in pancreas.
In addition, the relative abundance PPSS-II mRNA species in the stomach
was opposite that in the pancreas, such that the levels of
PPSS-II' mRNA were ~10-fold higher than those of
PPSS-II'' mRNA (Fig.
7B).
|
|
Abundance of PPSS-II'' mRNA is modulated
by nutritional state. Nutritional state modulated the
pattern of pancreatic PPSS-II mRNA expression. Fish that were fasted
for 2 wk displayed levels of PPSS-II'' mRNA that were
twofold higher than their continuously fed counterparts (Fig.
8). The levels of PPSS-II' mRNA,
however, were not affected by food deprivation.
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, we characterized two cDNAs that encode PPSS containing [Tyr7,Gly10]-SS-14 at their COOH terminus (designated PPSS-II' and PPSS-II'') and demonstrated that the two PPSS-II mRNAs are differentially expressed. This is the first report of the coexistence of two different PPSS-IIs. The nucleotide identity between the two cDNAs is 82.3%; the position and extent of the differences suggests the existence of two nonallelic PPSS-II genes. The two PPSS-IIs in rainbow trout are in addition to a single PPSS-I encoding SS-14, which also presumably arise from a separate gene (19).
The deduced PPSS-II' and PPSS-II'' proteins in
rainbow trout Brockmann bodies contain 115 and 111 amino acids,
respectively, both slightly shorter than the precursors of anglerfish
(16-18) and goldfish (20), the only other known PPSS-IIs
containing [Tyr7,Gly10]-SS-14.
Rainbow trout PPSS-II' shared 43.5% amino acid identity with
anglerfish PPSS-II and 51.3% amino acid identity with goldfish PPSS-II. The amino acid identity between rainbow trout
PPSS-II'' and anglerfish PPSS-II was 38.7%, whereas the
identity between trout PPSS-II'' and goldfish PPSS-II was
41.4%. Amino acid identities between rainbow trout PPSS-IIs and
precursors derived from gene 1 were lower, between 37.9 and 22.5%.
Rainbow trout PPSS-IIs were least similar to the PPSS, giving rise to
catfish SS-22. Although the evidence is limited, it appears that
evolutionary selection has acted to conserve the biologically active
COOH-terminal domain of PPSSs (Fig. 9).
|
A comparison of nucleotide and predicted amino acid sequences between SS-II' and SS-II'' of rainbow trout also helps to resolve questions surrounding the heterogeneity of the SS gene 2 family of peptides among teleosts. For example, 25-amino acid peptides with [Tyr7,Gly10]-SS-14 at their COOH terminus were isolated from eel (9) and coho salmon (33), whereas 28-amino acid peptides with [Tyr7,Gly10]-SS-14 have been isolated from anglerfish (18), flounder (8), goldfish (40), sculpin (8), and tilapia (28). The present findings in trout, in which PPSS-II' possesses a putative Arg processing site that would give rise to a 28-amino acid peptide containing [Tyr7,Gly10]-SS-14 and in which PPSS-II'' possesses a putative Arg processing site that would give rise to a 25-amino acid peptide containing [Tyr7,Gly10]-SS-14, suggest that the difference between the 28- and 25-amino acid forms results from a nine nucleotide deletion in the SS coding region.
SS emerged early during the course of evolution. Immunocytochemical evidence places SS in several invertebrate groups, including invertebrate chordates (32), arthropod insects (14), and gastropod mollusks (22). Among vertebrates, a multigenic origin of SS is supported by both cDNA and peptide sequence data. The widespread distribution of SS-14 among vertebrates, from lamprey to mammals (10), suggests strong conservation of the gene (SS gene 1) encoding it. This notion is supported by available cDNA information (2). Structural data also point to the emergence of additional SS genes. Lamprey, for example, possess variant forms of SS (three successively longer peptides extended at their NH2 terminus) in addition to SS-14 (1). A variety of peptide sequence data as well as limited cDNA information suggests that teleost fish also possess multiple SS genes. A majority of the reports suggests the existence of two genes: one encoding [Tyr7,Gly10]-SS-14 and one encoding SS-14 (8). Recent reports suggest that some teleosts possess more than two SS genes. For example, the present study shows that rainbow trout possess two distinct cDNAs that give rise to two different PPSSs containing [Tyr7,Gly10]-SS-14 at their COOH termini as well as a third cDNA encoding SS-14 (19). In addition, a recent report also showed that goldfish possess three distinct cDNAs: one encoding SS-14, a second encoding [Glu1,Tyr7,Gly10]-SS-14, and a third encoding [Pro2]-SS-14 (20). The presence of multiple SS genes also extends to the tetrapods. Frogs possess one cDNA that encodes for a PPSS containing [Pro2,Met13]-SS-14 and a second cDNA that encodes a PPSS that contains SS-14 (38). In addition, mammalian cortistatin, a peptide sharing considerable identity to SS-14 that was isolated from the brain of rats (11) may be derived from an alternate SS gene form that emerged in early tetrapod evolution. Whether or not the various SS genes in vertebrates arose through several independent gene duplication events or through a single duplication event predating or concomitant with the appearance of Agnatha, as suggested by Conlon et al. (10), is not known.
Because SS-II' and SS-II'' of rainbow trout are more closely related to each other than either are to other SS-II or SS-I cDNAs, the duplication event leading to their emergence, probably the tetraploidization event that appears common to salmonids (30), likely occurred after the duplication, giving rise to the two teleost SS genes, an event estimated to have occurred some 160 million years ago (37). Tetraploidy may also help to explain the presence of multiple SSs in goldfish (20).
The two PPSS-II mRNAs of rainbow trout are differentially expressed. This conclusion is based on several observations. First, the pattern of PPSS-II' mRNA and PPSS-II'' mRNA is tissue specific. For example, only PPSS-II'' mRNA was detected in the brain of rainbow trout, whereas both PPSS-II' and PPSS-II'' mRNA were detected in pancreas and various regions of the gut. Brain-specific expression of the mRNA encoding the alternate form of SS in frogs (denoted PSS2) (38) and cortistatin (11) also has been reported. Previous immunocytochemical studies support a similar distribution of [Tyr7,Gly10]-SS-14-containing peptides in the intestine (4) and stomach (3) of rainbow trout. Second, the abundance of PPSS-II mRNAs was different with specific tissues. Within the Brockmann body of rainbow trout, the predominant message form was that encoding for PPSS-II'', whereas in the stomach the predominant form was that encoding PPSS-II'. Finally, the pattern of PPSS-II expression within the endocrine pancreas of rainbow trout was modulated by nutritional state. Together, these results suggest that rainbow trout produce two forms of gene 2 SS peptides and that there exist mechanisms to independently regulate the expression of each.
The alternate forms of SS (containing [Tyr7,Gly10]-SS-14) in rainbow trout are in addition to SS-14 (19). The functions of the various SS peptides remain to be fully elucidated; however, previous research has suggested that distinctive roles for the gene 1 and gene 2 forms exist. For example, peptides derived from gene 1 (e.g., SS-14, SS-28) were equipotent in their ability to inhibit the release of growth hormone from goldfish pituitary fragments in vitro, whereas peptides derived from alternate genes (e.g., sSS-25, catfish SS-22) had no effect on growth hormone release (23). Similarly, salmonid SS-25 (from gene 2) inhibited insulin in rainbow trout, but SS-14 (from gene 1) did not (13).
In summary, the present report describes the characterization of two cDNAs encoding for PPSSs that contain [Tyr7,Gly10]-SS-14, consistent with the existence of two nonallelic SS genes and that the mRNAs for the two PPSSs (PPSS-II' and PPSS-II'') are differentially expressed. These results support the notion of a polygenic origin of somatostatins and suggest the existence of mechanisms to control the differential expression of the multiple SS genes. The regulation of differential gene expression may underlie aspects of the multifunctional nature of the SS family of peptides. Future studies will be conducted to evaluate how differential expression of PPSS-II' and PPSS-II'' is regulated.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Dave Allmer, Jean Boser, and Jayme Steig for technical assistance. Fish were generously provided by the North Dakota Department of Game and Fish and the US Department of the Interior, Fish and Wildlife Service (Garrison National Hatchery).
| |
FOOTNOTES |
|---|
This work was supported by grants from the National Science Foundation (OSR-9452892 and IBN-9723058).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: M. A. Sheridan, Dept. of Zoology, North Dakota State Univ., Fargo, ND 58102 (E-mail: msherida{at}plains.nodak.edu).
Received 31 March 1999; accepted in final form 16 July 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Andrews, P. C.,
H. G. Pollock,
W. M. Elliott,
J. H. Youson,
and
E. M. Plisetskaya.
Isolation and characterization of a variant somatostatin-14 and two related somatostatins of 34 and 37 residues from lamprey (Petromyzon marinus).
J. Biol. Chem.
263:
15809-15814,
1988
2.
Argos, P.,
W. L. Taylor,
C. D. Minth,
and
J. E. Dixon.
Nucleotide and amino acid sequence comparisons of preprosomatostatins.
J. Biol. Chem.
258:
8788-8793,
1983
3.
Barrenechea, M. A.,
J. Lopez,
and
A. Martinez.
Regulatory peptides in gastric endocrine cells of the rainbow trout, Oncorhynchus mykiss: general distribution and colocalizations.
Tissue Cell
26:
309-321,
1994[Medline].
4.
Beorlegegui, C.,
A. Martinez,
and
P. Sesma.
Endocrine cells and nerves in the pyloric ceca and the intestine of Oncorhynchus mykiss (Teleostei): an immunocytochemical study.
Gen. Comp. Endocrinol.
86:
483-495,
1992[Medline].
5.
Brazeau, P.,
W. Vale,
R. Burgus,
N. Ling,
M. Butcher,
J. Rivier,
and
R. Guillemin.
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.
Science
179:
77-79,
1973
6.
Celi, F. S.,
K. Tanner,
A. K. Roth,
A. E. Roth,
and
A. R. Shuldiner.
The two nonallelic Xenopus insulin genes are expressed coordinately in the adult pancreas.
Gen. Comp. Endocrinol.
95:
169-177,
1994[Medline].
7.
Conlon, J. M.
Biosynthesis of regulatory peptides
evolutionary aspects.
In: The Comparative Physiology of Regulatory Peptides, edited by S. Holmgren. London/New York: Chapman and Hull, 1989, p. 174-202.
8.
Conlon, J. M.,
M. S. Davis,
S. Falkmer,
and
L. Thim.
Structural characterization of peptides derived from preprosomatostatin I and II isolated from the pancreatic islets of two species of teleostean fish: the daddy sculpin and the flounder.
Eur. J. Biochem.
168:
657-662,
1987.
9.
Conlon, J. M.,
C. F. Deacon,
N. Hazon,
I. W. Henderson,
and
L. Thim.
Somatostatin-related and glucagon-related peptides with unusual structural features from the European eel (Auguilla auguilla).
Gen. Comp. Endocrinol.
72:
181-189,
1988[Medline].
10.
Conlon, J. M.,
H. Tostivint,
and
H. Vaudry.
Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives.
Regul. Pept.
69:
95-103,
1997[Medline].
11.
DeLecea, L.,
J. R. Criado,
O. Prospero-Garcia,
K. M. Gautvik,
P. Schweitzer,
P. E. Danielson,
C. L. M. Dunlop,
G. R. Siggins,
S. G. Henriksen,
and
J. G. Sutcliffe.
A cortical neuropeptide with neuronal depressant and sleep-modulating properties.
Nature
381:
242-245,
1996[Medline].
12.
Del Sal, G.,
G. Manfioletti,
and
C. Schneider.
The CTAB-DNA precipitation method: a common mini-scale preparation of template DNA from phagemids, phages or plasmids suitable for sequencing.
Biotechniques
7:
514-519,
1989[Medline].
13.
Eilertson, C. D.,
and
M. A. Sheridan.
Differential effects of somatostatin-14 and somatostatin-25 on carbohydrate and lipid metabolism in rainbow trout, Oncorhynchus mykiss.
Gen. Comp. Endocrinol.
92:
62-70,
1993[Medline].
14.
Fujita, T.,
R. Yui,
T. Iwanaga,
J. Nishiitsutsuji-Uwo,
Y. Endo,
and
N. Yanaihara.
Evolutionary aspects of "brain-gut peptides": an immunohistochemical study.
Peptides
2:
123-131,
1981.
15.
Goodman, R. H.,
P. C. Aaron,
and
G. A. Roose.
Rat pre-prosomatostatin. Structure and processing by microsomal membranes.
J. Biol. Chem.
258:
570-573,
1983.
16.
Goodman, R. H.,
J. W. Jacobs,
W. W. Chin,
D. K. Lund,
P. C. Dee,
and
J. F. Habener.
Nucleotide sequence of a cloned structural gene coding for a precursor of pancreatic somatostatin.
Proc. Natl. Acad. Sci. USA
77:
5869-5873,
1980
17.
Goodman, R. H.,
J. W. Jacobs,
W. W. Chin,
P. K. Lund,
P. C. Dee,
and
J. F. Habener.
Nucleotide sequence of a cloned structural gene coding for a precursor of a pancreatic somatostatin (correction).
Proc. Natl. Acad. Sci. USA
79:
1682,
1982
18.
Hobart, P.,
R. Crawford,
L. Shen,
R. Pictet,
and
W. J. Rutter.
Cloning and sequence analysis of cDNAs encoding two distinct somatostatin precursors found in the endocrine pancreas of anglerfish.
Nature
288:
137-141,
1980[Medline].
19.
Kittilson, J. D.,
C. A. Moore,
and
M. A. Sheridan.
Polygenic expression of somatostatin in trout pancreas: evidence of a preprosomatostatin encoding somatostatin-14.
Gen. Comp. Endocrinol.
114:
88-96,
1999[Medline].
20.
Lin, X.,
C. J. Otto,
and
R. E. Peter.
Expression of three distinct somatostatin messenger ribonucleic acids (mRNAs) in goldfish brain: characterization of the complementary deoxyribonucleic acids, distribution and seasonal variation of the mRNAs, and action of a somatostatin-14 variant.
Endocrinology
140:
2089-2099,
1999
21.
Magazin, M.,
C. D. Minth,
C. L. Funches,
R. Deschenes,
M. Tavianini,
and
J. E. Dixon.
Sequence of a cDNA encoding pancreatic preprosomatostatin-22.
Proc. Natl. Acad. Sci. USA
79:
5152-5156,
1982
22.
Marchand, C. R.,
L. Assaka,
and
M. T. Strosser.
Variations of somatostatin-like immunoreactivity in the circumoesophageal ganglia, the hepatopancreas, the mantle edge, and the hemolymph of shell-repairing snails (Helis aspersa).
Gen. Comp. Endocrinol.
73:
59-68,
1989[Medline].
23.
Marchant, T. A.,
and
R. E. Peter.
Hypothalamic peptides influencing growth hormone secretion in the goldfish, Carassius auratus.
Fish Physiol. Biochem.
7:
133-139,
1989.
24.
Minth, C. D.,
W. L. Taylor,
M. Magazin,
M. A. Tavianini,
K. Collier,
H. L. Weith,
and
J. E. Dixon.
The structure of cloned DNA complementary to catfish pancreatic somatostatin-14 messenger RNA.
J. Biol. Chem.
257:
10372-10377,
1982
25.
Moore, C. A.,
J. D. Kittilson,
S. K. Dahl,
and
M. A. Sheridan.
Isolation and characterization of a cDNA encoding for preprosomatostatin containing [Tyr7,Gly10]-somatostatin-14 from the endocrine pancreas of rainbow trout, Oncorhynchus mykiss.
Gen. Comp. Endocrinol.
98:
253-261,
1995[Medline].
26.
Mullis, K. B.
The polymerase chain reaction in an anemic mode: how to avoid cold oligodeoxyribonuclear fusion.
PCR Methods Appl.
1:
1-4,
1991[Medline].
27.
Nata, K. G. Domesticus mRNA for Somatostatin-14 and
Somatostatin-28. GenBank direct submission.
Accession No. X60191, 1991.
28.
Nguyen, T. M.,
J. R. Wright, Jr.,
P. F. Neilsen,
and
J. M. Conlon.
Characterization of the pancreatic hormones from the Brockmann body of the tilapia: implications for islet xenograft studies.
Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol.
111C:
33-44,
1995[Medline].
29.
Nozaki, M.,
K. Miyata,
Y. Oota,
A. Gorbman,
and
E. M. Plisetskaya.
Different cellular distributions of two somatostatins in brain and pancreas of salmonids and their association with insulin- and glucagon-secreting cells.
Gen. Comp. Endocrinol.
69:
267-280,
1988[Medline].
30.
Ohno, S.
Evolution by Gene Duplication. Berlin: Springer-Verlag, 1970.
31.
Patel, Y. C.
General aspects of the biology and function of somatostatin.
In: Basic and Clinical Aspects of Neuroscience, edited by C. Weil,
E. E. Mueller,
and M. O. Thorner. Berlin: Springer-Verlag, 1992, vol. 4, p. 1-16.
32.
Pearse, A. G. E.
The phylogeny of the common peptides (Chairman's address).
Proc. R. Soc. Lond. B Biol. Sci.
B210:
61-62,
1980
33.
Plisetskaya, E. M.,
H. G. Pollock,
J. B. Roose,
J. W. Hamilton,
J. R. Kimmel,
P. C. Andrews,
and
A. Gorbman.
Characterization of coho salmon (Oncorhynchus kisutch) islet somatostatins.
Gen. Comp. Endocrinol.
63:
252-263,
1986[Medline].
34.
Sambrook, J.,
E. F. Fritsch,
and
T. Maniatis.
Molecular Cloning: A Laboratory Manual (2nd ed.). Plainview, NY: Cold Spring Harbor Laboratory Press, 1989.
35.
Shen, L. P.,
R. L. Pictet,
and
W. J. Rutter.
Human somatostatin I: sequence of the cDNA.
Proc. Natl. Acad. Sci. USA
79:
4575-4579,
1982
36.
Shuldiner, A. R.,
K. Tanner,
C. A. Moore,
and
J. Roth.
RNA template-specific PCR (RS-PCR): an improved method that dramatically reduces false positives in RT-PCR.
Biotechniques
11:
760-763,
1991[Medline].
37.
Su, C. J.,
J. W. White,
W. H. Li,
C. C. Luo,
M. L. Frazier,
G. F. Saunders,
and
L. Chan.
Structure and evolution of somatostatin genes.
Mol. Endocrinol.
2:
209-216,
1988
38.
Tostivint, H.,
I. Lihrmann,
C. Bucharles,
D. Vieau,
Y. Coulouarn,
A. Fournier,
J. M. Conlon,
and
H. Vaudry.
Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs and receptor-binding affinities of the peptides.
Proc. Natl. Acad. Sci. USA
93:
12605-12610,
1996
39.
Travis, G. H.,
and
J. G. Sutcliffe.
Phenol emulsion-enhanced DNA-driven subtractive cDNA cloning: isolation of low abundance monkey cortex-specific mRNAs.
Proc. Natl. Acad. Sci. USA
85:
1696-1700,
1988
40.
Uesaka, T.,
K. Yano,
M. Yamasaki,
and
M. Ando.
Somatostatin, vasoactive intestinal peptide, and granulin-like peptides isolated from intestinal tracts of goldfish (Carassius auratus).
Gen. Comp. Endocrinol.
99:
298-306,
1995[Medline].
This article has been cited by other articles:
![]() |
P.-Y. Rescan, I. Jutel, and C. Ralliere Two myostatin genes are differentially expressed in myotomal muscles of the trout (Oncorhynchus mykiss) J. Exp. Biol., March 12, 2002; 204(20): 3523 - 3529. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Holloway, G. T. Melroe, M. M. Ehrman, P. K. Reddy, J. F. Leatherland, and M. A. Sheridan Effect of 17beta -estradiol on the expression of somatostatin genes in rainbow trout (Oncorhynchus mykiss) Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R389 - R393. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |